<< Herbal dietary supplements may contain toxic metals | Fera acquires investigational new drug for treatment of fungal otitis externa >>
Read in | English | Filipino | Svenska

New research identifies stem cells that generate three critical classes of nerve cells

Published on July 22, 2010 at 4:29 AM · No Comments

GW's Dr. Anthony-Samuel LaMantia publishes research on neural precursors in the developing olfactory ephithelium

New research, published in the journal Development, by Dr. Anthony-Samuel LaMantia, professor of Pharmacology & Physiology and director of the newly formed GW Institute for Neuroscience, and his colleagues have identified the stem cells that generate three critical classes of nerve cells - olfactory receptors (ORNs), vomeronasal (VRNs) and gonadotropin releasing hormone (GnRH) neurons - that are responsible for enabling animals and humans, to eat, interact socially and reproduce.

This research is the first evidence identfying these stem cells. By studying mice at the earliest stages of embryonic development, LaMantia and his colleagues were able to identify the location of these cells, confirm that they divide slowly and symmetrically-thus making more stem cells, have a distinct molecular identity, and give rise to all cell types in the tissue-including ORNs, VRNs and GnRH neurons. These embryonic olfactory stem cells also are ultimately responsible for generating stem cells that remain in the lining of the nose throughout life and make new ORNs and VRNs. Thus these stem cells are also essential to enable a rare example of nervous system regeneration that continues throughout life.

"By identifying these stems cells, our research will help physicians understand why people have certain genetic, neurological, and mental disabilities. Olfaction is often compromised early in the course of a number of serious diseases including autism, schizophrenia, and Alzheimer's disease, and GnRH deficiency is important in many cases of infertility. It is my hope that in the future, we will combine this sort of cell and molecular biology with clinical practice to develop better treatments for patients with these disorders," said Dr. LaMantia.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading